StockData
Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc. (CLRB) stock

CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.01−0.13 (-11.40%)

Close on Nov 16, 2026Market cap $9.55MP/E –Yield –

Cellectar Biosciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Cellectar Biosciences's enterprise value was -$24.01M on Nov 11, 2026, against -$1.09M a year earlier. Over the last 5 years it ranged from -$24.06M to $73.00M, with a median of -$2.17M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$24.01M–
2025Dec 31, 2025-$3.14M–
2024Dec 31, 2024-$22.13M-360.7%
2023Dec 29, 2023$8.49M–
2022Dec 30, 2022-$7.34M-3281.4%
2021Dec 31, 2021$230.59K-99.4%
2020Dec 31, 2020$36.94M+372.3%
2019Dec 31, 2019$7.82M–
2018Dec 31, 2018-$9.81M-177.0%
2017Dec 29, 2017$12.75M+1312.5%
2016Dec 30, 2016$902.43K-72.4%
2015Dec 31, 2015$3.27M-73.0%
2014Dec 31, 2014$12.13M-27.1%
2013Dec 31, 2013$16.65M-34.1%
2012Dec 31, 2012$25.27M+135.3%
2011Dec 30, 2011$10.74M–

More Cellectar Biosciences figures

See a number that looks wrong?